The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
Open accessAbstract
15-deoxy-Delta12,14-PGJ2 (15d-PGJ2) has been identified as an endogenous ligand for PPARgamma, inducing adipogenesis in vitro. Additional roles for this molecule in the propagation and resolution of inflammation, ligation of NF-kappaB, and mediation of apoptosis have been proposed. However, quantitative, physiochemical evidence for the formation of 15d-PGJ2 in vivo is lacking. We report that 15d-PGJ2 is detectable using liquid chromatography-mass spectrometry-mass spectrometry at low picomolar concentrations in the medium of 3T3-L1 preadipocytes. However, despite induction of COX-2, production of PGs, including 15d-PGJ2, does not increase during adipocyte differentiation, a process unaltered by COX inhibition. 15d-PGJ2 is detectable as a minor product of COX-2 in human urine. However, its biosynthesis is unaltered during or after COX activation in vivo by LPS. Furthermore, the biosynthesis of 15d-PGJ2 is not augmented in the joint fluid of patients with arthritis, nor is its urinary excretion increased in patients with diabetes or obesity. 15d-PGJ2 is not the endogenous mediator of PPARgamma-dependent adipocyte activation and is unaltered in clinical settings in which PPARgamma activation has been implicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956 · cited 3×
“Among the genes regulated by PPARγ, many are involved in lipid metabolism, including lipoprotein lipase (LPL), adipocyte fatty acid binding protein (aP2), acyl-CoA synthase, and fatty acid transport protein (2, 3).”
BackgroundPPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth
Rosen, E. D., & Spiegelman, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100034200 · Cited by 1,175
Platelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Self-citationLehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110 · cited 2×
“NSAIDs have been shown to bind and activate PPARα and PPARγ in vitro (43) at high concentrations.”
BackgroundMethod15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Jakobsson, P.-J., Thorén, S., Morgenstern, R., & Samuelsson, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7220 · Cited by 996
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789
Self-citationSmith, J. D., Trogan, E., Ginsberg, M., Grigaux, C., Tian, J., & Miyata, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8264 · Cited by 724
Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
Straus, D. S., & Glass, C. K. (2001) · Medicinal Research Reviews · doi:10.1002/med.1006 · Cited by 576
Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., & Gregory, S. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118717 · Cited by 571
Genetic and pharmacological analysis of prostanoid receptor function
Narumiya, S., & FitzGerald, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13455 · Cited by 568
Self-citationCyclopentenone prostaglandins: New insights on biological activities and cellular targets
Straus, D. S., & Glass, C. K. (2001) · Medicinal Research Reviews · doi:10.1002/med.1006.abs · Cited by 520
Barry, O. P., Pratico, D., Lawson, J. A., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119385 · Cited by 480
Self-citationRelease of Prostaglandin D2into Human Airways during Acute Antigen Challenge
Murray, J. J., Tonnel, A. B., Brash, A. R., Roberts, L. J., Gosset, P., Workman, R., Capron, A., & Oates, J. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609253151304 · Cited by 469
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
FitzGerald, G. A., Pedersen, A. K., & Patrono, C. (1983) · Circulation · doi:10.1161/01.cir.67.6.1174 · Cited by 466
Self-citation15-Deoxy-Δ12,14-prostaglandin J2
Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M., & Uchida, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110314200 · Cited by 392
Wright, H. M., Clish, C. B., Mikami, T., Hauser, S., Yanagi, K., Hiramatsu, R., Serhan, C. N., & Spiegelman, B. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1873 · Cited by 368
Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro.
Fitzpatrick, F. A., & Wynalda, M. A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44287-6 · Cited by 328
Transcription coactivator TRAP220 is required for PPARγ2-stimulated adipogenesis
Ge, K., Guermah, M., Yuan, C.-X., Ito, M., Wallberg, A. E., Spiegelman, B. M., & Roeder, R. G. (2002) · Nature · doi:10.1038/417563a · Cited by 319
T RANSCRIPTIONAL C ONTROL OF A DIPOGENESIS
Rangwala, S. M., & Lazar, M. A. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.535 · Cited by 319
A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
Oberfield, J. L., Collins, J. L., Holmes, C. P., Goreham, D. M., Cooper, J. P., Cobb, J. E., Lenhard, J. M., Hull-Ryde, E. A., Mohr, C. P., Blanchard, S. G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6102 · Cited by 316
Shi, Y., Hon, M., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052707099 · Cited by 303
PPARadigms and PPARadoxes: expanding roles for PPARγ in the control of lipid metabolism
Walczak, R., & Tontonoz, P. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30159-0 · Cited by 270
Estimated rate of prostacyclin secretion into the circulation of normal man.
FitzGerald, G. A., Brash, A. R., Falardeau, P., & Oates, J. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110373 · Cited by 269
Self-citationDavies, S. S., Pontsler, A. V., Marathe, G. K., Harrison, K. A., Murphy, R. C., Hinshaw, J. C., Prestwich, G. D., Hilaire, A. S., Prescott, S. M., Zimmerman, G. A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100878200 · Cited by 266
McAdam, B. F., Mardini, I. A., Habib, A., Burke, A., Lawson, J. A., Kapoor, S., & FitzGerald, G. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9523 · Cited by 253
Self-citationFrungieri, M. B., Weidinger, S., Meineke, V., Köhn, F. M., & Mayerhofer, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232422999 · Cited by 252
Estimated rate of thromboxane secretion into the circulation of normal humans.
Patrono, C., Ciabattoni, G., Pugliese, F., Pierucci, A., Blair, I. A., & FitzGerald, G. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112341 · Cited by 234
Self-citationRosen, K., Coll, M. L., Li, A., & Filmus, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106424200 · Cited by 202
Prostaglandin D2 in rat brain, spinal cord and pituitary: Basal level and regional distribution
Narumiya, S., Ogorochi, T., Nakao, K., & Hayaishi, O. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90101-1 · Cited by 201
PPARγ and Atherosclerosis: Effects on Cell Growth and Movement
Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100261 · Cited by 191
Hoffmann, A., Conradt, H. S., Gross, G., Nimtz, M., Lottspeich, F., & Wurster, U. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb02145.x · Cited by 181
Xue, J.-C., Schwarz, E. J., Chawla, A., & Lazar, M. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1567 · Cited by 181
Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara, S., Takabayashi, A., Yamaoka, Y., & Yodoi, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6689 · Cited by 174
Li, H., Lawson, J. A., Reilly, M., Adiyaman, M., Hwang, S.-W., Rokach, J., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13381 · Cited by 161
Self-citationFormation of Reactive Cyclopentenone Compounds in Vivo as Products of the Isoprostane Pathway
Chen, Y., Morrow, J. D., & Roberts, L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10863 · Cited by 155
Kikawa, Y., Narumiya, S., Fukushima, M., Wakatsuka, H., & Hayaishi, O. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1317 · Cited by 153
Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine.
Hirata, Y., Hayashi, H., Ito, S., Kikawa, Y., Ishibashi, M., Sudo, M., Miyazaki, H., Fukushima, M., Narumiya, S., & Hayaishi, O. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37435-0 · Cited by 145
Narumiya, S., Ohno, K., Fukushima, M., & Fujiwara, M. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39070-1 · Cited by 138
Bombardieri, S., Cattani, P., Ciabattoni, G., Munno, O. D., Pasero, G., Patrono, C., Pinca, E., & Pugliese, F. R. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb08743.x · Cited by 136
Ward, C., Dransfield, I., Murray, J., Farrow, S. N., Haslett, C., & Rossi, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6232 · Cited by 131
Kunapuli, P., Lawson, J. A., Rokach, J., Meinkoth, J. L., & FitzGerald, G. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22442 · Cited by 119
Self-citationMetabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer.
Liston, T. E., & Roberts, L. J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38853-1 · Cited by 103
Atsmon, J., Freeman, M. L., Meredith, M. J., Sweetman, B. J., & Roberts, L. J. (1990) · PubMed · Cited by 90
Atsmon, J., Sweetman, B. J., Baertschi, S. W., Harris, T. M., & Roberts, L. J. (1990) · Biochemistry · doi:10.1021/bi00467a023 · Cited by 88
The activation of specific gene transcription in the adipose conversion of 3T3 cells
Djian, P., Phillips, M. A., & Green, H. (1985) · Journal of Cellular Physiology · doi:10.1002/jcp.1041240327 · Cited by 80
Progress in cardiovascular biology: PPAR for the course
Lazar, M. A. (2001) · Nature Medicine · doi:10.1038/83301 · Cited by 66
Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin.
Braden, G. A., Knapp, H. R., & FitzGerald, G. A. (1991) · Circulation · doi:10.1161/01.cir.84.2.679 · Cited by 55
Self-citationMetabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis
Roberts, L. J., & Sweetman, B. J. (1985) · Prostaglandins · doi:10.1016/0090-6980(85)90114-5 · Cited by 48
COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation?
Colville‐Nash, P., & Gilroy, D. W. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00074-5 · Cited by 48
McCloskey, H. M., Rothblat, G. H., & Glick, J. M. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90033-6 · Cited by 46
The nature and composition of 15-deoxy-Δ12,14PGJ2
Maxey, K. M., Hessler, E. J., MacDonald, J., & Hitchingham, L. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00072-1 · Cited by 41
Kikawa, Y., Narumiya, S., & Fukushima, M. (1984) · Cited by 26
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Self-citationMechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
Lehrke, M., & Lazar, M. A. (2005) · Cell · doi:10.1016/j.cell.2005.11.026 · Cited by 1,443
Hypoxia and Adipose Tissue Function and Dysfunction in Obesity
Trayhurn, P. (2013) · Physiological Reviews · doi:10.1152/physrev.00017.2012 · Cited by 878
Metadata
- Authors
- Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M., & FitzGerald, G. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-09-15
- Volume
- 112
- Issue
- 6
- Pages
- 945-955
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2093584890
- Cited by
- 341
- References
- 60
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.